Job title: Director & Precision Medicine Lead
Benoit Destenaves has 18 years of experience in the biotechnology and pharmaceutical industry specializing in the analysis of molecular biomarkers.
Benoit started his career in 1999 working for Genset, a French Biotech company that specialized in pharmacogenomics. He then worked for Serono/Merck Serono where he held positions of increasing responsibility linked to precision medicine in oncology, endocrinology and fertility.
He joined AstraZeneca in 2013 to lead the molecular diagnostics labs and Pharmacogenomics group within the Precision Medicine and Genomics Function where he developed the group’s focus on novel approaches (ctDNA, NGS) for companion diagnostics. In his current role, he leads strategic diagnostic and precision medicine projects for AstraZeneca.
Panel Discussion 4:30 pm
• Tackling assay validation and ensuring markers are clinically applicable for expedited drug development • Finding the specific driver of disease: How far can current technologies take us? • Cost vs quality: Avoiding false positives by finding the right, cost-effective technology for your biomarkerRead more
day: Day One
What’s New? An Overview of the Liquid Biopsy Space 9:00 am
• Uncovering the latest advancements, challenges and strategies seen across the liquid biopsy field • Discussing the current state of play on clinical use and uptake of liquid biopsies: How do we advance this even further? • Where next? Taking a look into what’s on the horizon for non-invasive tests and key next steps for…Read more
day: Day One